Introducing Providence St. Joseph Health Digital Commons

December 6, 2018 Providence News Team


Digital Commons features presentations by Providence researchers at national meeting

Providence St. Joseph Health (PSJH) recently launched a new platform to highlight the scholarly activities of its providers, researchers and caregivers: Digital Commons. The institutional repository serves as a singular site to easily access and navigate PSJH journal articles, abstracts, book chapters, presentations and other materials.

new collection on Digital Commons features the research presented by members of the Earle A. Chiles Research Institute at the 2018 annual meeting of the Society for Immunotherapy of Cancer held November 7-11 in Washington, D.C. Institute researchers contributed to more than 20 abstracts presented at the national conference, including 15 first-author abstracts and an oral abstract presentation by David Page, M.D., medical oncologist and assistant member, Breast Cancer Immunotherapy. View the collection of full text abstracts and posters, and sign up for notification of future collections, here.

About the Earle A. Chiles Research Institute

The Earle A. Chiles Research Institute is a division of Providence Cancer Institute located at the Robert W. Franz Cancer Center in Portland, Oregon. Since 1993, we have focused almost exclusively on the investigation of immunotherapy for cancer. Our team has contributed to major advancements in the rapidly developing field of cancer immunotherapy, such as leading the global clinical trial of the first FDA-approved cancer immunotherapy agent ipilimumab, launching the first-in-human clinical trial of anti-OX40, and establishing one of the most robust clinical trial portfolios for head and neck cancer in the Western United States. Learn more about our accomplishments in our annual reports.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.

More Content by Providence News Team
Previous Article
Melanoma study: are two immunotherapies better than one?
Melanoma study: are two immunotherapies better than one?

A newly opened Phase 3 study at Providence Cancer Institute hopes to shed new light on the benefits of two ...

Next Article
KATU AM Northwest: Holiday Nutrition Tips
KATU AM Northwest: Holiday Nutrition Tips

Becky McCarver talks about holiday nutrition on KATU AM Northwest.